Bartlett & Co’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-74,000
Closed -$592K 699
2017
Q1
$592K Hold
74,000
0.03% 186
2016
Q4
$688K Hold
74,000
0.03% 170
2016
Q3
$784K Hold
74,000
0.04% 160
2016
Q2
$691K Hold
74,000
0.03% 168
2016
Q1
$769K Sell
74,000
-1,000
-1% -$9.14K 0.04% 155
2015
Q4
$754K Hold
75,000
0.04% 161
2015
Q3
$631K Hold
75,000
0.03% 164
2015
Q2
$1.21M Hold
75,000
0.06% 137
2015
Q1
$1.06M Hold
75,000
0.05% 146
2014
Q4
$749K Sell
75,000
-5,100
-6% -$43.7K 0.04% 160
2014
Q3
$682K Sell
80,100
-15,000
-16% -$132K 0.03% 164
2014
Q2
$841K Buy
95,100
+11,100
+13% +$96.9K 0.04% 160
2014
Q1
$783K Sell
84,000
-6,000
-7% -$52.6K 0.04% 158
2013
Q4
$760K Hold
90,000
0.04% 158
2013
Q3
$793K Hold
90,000
0.04% 155
2013
Q2
$639K Buy
+90,000
New +$622K 0.04% 160

Other funds holding OPK

Bartlett & Co's OPK Position: Q2 2017 in Review

Bartlett & Co sold out of Opko Health (OPK) in Q2 2017, closing a stake of 74,000 shares — an estimated $592K sold.

Bartlett & Co first reported a position in OPK in Q2 2013 and held it in 16 quarters. The position peaked at $1.21M in Q2 2015. 232 funds tracked by Wall St. Rank hold OPK as of Q2 2017.

  • Bartlett & Co reported no remaining Opko Health position as of Q2 2017 after selling out during the quarter.
  • Bartlett & Co sold 74,000 Opko Health shares in Q2 2017, an estimated $592K.
  • Bartlett & Co first reported a position in Opko Health in Q2 2013 and held it in 16 quarters.
  • Bartlett & Co's Opko Health position peaked at $1.21M in Q2 2015.
  • 232 funds tracked by Wall St. Rank held Opko Health as of Q2 2017.

Based on Bartlett & Co's 13F filing for Q2 2017, filed 18 Jul 2017.